Basics Precision BioSciences, Inc. IPO Date: May 25, 2019 Sector: Healthcare Industry: Biotech Market Cap: $82.39M Activated in VL: True Average Daily Range Avg Daily Range: $0.24 | 3.66% Avg Daily Range (30 D): $0.15 | 2.77% Avg Daily Range (90 D): $0.14 | 2.88% Institutional Daily Volume Avg Daily Volume: .6M Avg Daily Volume (30 D): .12M Avg Daily Volume (90 D): .17M Trade Size Avg Trade Size (Sh.): 167 Avg Trade Size (Sh.) (30 D): 144 Avg Trade Size (Sh.) (90 D): 98 Institutional Trades Total Inst.Trades: 324 Avg Inst. Trade: $1.41M Avg Inst. Trade (30 D): $.72M Avg Inst. Trade (90 D): $.69M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.55M Avg Closing Trade (30 D): $.62M Avg Closing Trade (90 D): $.62M Avg Closing Volume: 7.43K     News Mar 5, 2025 @ 6:00 PM CAR T-cell Therapy Clinical Trial Pipeline Experie... Source: Delveinsight Sep 10, 2024 @ 9:00 AM Global Genetic Engineering Market Size To Worth US... Source: Spherical Insights & Consulting Sep 10, 2024 @ 8:51 AM Gene Editing Therapeutics Market Forecast 2024-202... Source: Researchandmarkets.Com May 29, 2024 @ 1:55 PM Does Precision BioSciences (DTIL) Have the Potenti... Source: Zacks Equity Research May 16, 2024 @ 6:00 PM Deep Dive Into Precision BioSciences Stock: Analys... Source: Benzinga Insights Financials   TTM Q2 2025 Q1 2025 Basic EPS $-9.41 $-2.13 $-2.21 Diluted EPS $-9.33 $-2.13 $-2.21 Revenue $ 1.26M $ .02M $ .03M Gross Profit $ $ $ Net Income / Loss $ -78.26M $ -23.52M $ -20.57M Operating Income / Loss $ -90.11M $ -21.88M $ -22.11M Cost of Revenue $ $ $ Net Cash Flow $ -38.77M $ -14.98M $ -8.68M PE Ratio     Splits Feb 14, 2024:   1:30